WW
JAZZ icon

Waterfront Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History

Waterfront Wealth’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.91M Buy
15,382
+1,704
+12% +$298K 0.53% 55
2025
Q4 		$2.31M Buy
13,678
+27
+0.2% +$4.14K 0.44% 66
2025
Q3 		$1.88M Buy
13,651
+2,669
+24% +$320K 0.39% 75
2025
Q2 		$1.17M Sell
10,982
-388
-3% -$42.1K 0.26% 114
2025
Q1 		$1.41M Buy
11,370
+1,695
+18% +$221K 0.34% 83
2024
Q4 		$1.19M Buy
9,675
+137
+1% +$16.1K 0.29% 104
2024
Q3 		$1.06M Buy
9,538
+127
+1% +$13.9K 0.26% 121
2024
Q2 		$1M Buy
9,411
+230
+3% +$25.3K 0.27% 115
2024
Q1 		$983K Buy
9,181
+548
+6% +$67.1K 0.28% 109
2023
Q4 		$1.06M Buy
8,633
+103
+1% +$12.9K 0.31% 96
2023
Q3 		$1.1M Buy
8,530
+378
+5% +$50.4K 0.36% 81
2023
Q2 		$1.08M Buy
8,152
+841
+12% +$113K 0.32% 89
2023
Q1 		$1.07M Buy
7,311
+512
+8% +$75.7K 0.35% 82
2022
Q4 		$1.06M Buy
6,799
+232
+4% +$34K 0.36% 78
2022
Q3 		$931K Buy
6,567
+1,281
+24% +$195K 0.35% 86
2022
Q2 		$825K Buy
5,286
+2,275
+76% +$350K 0.33% 85
2022
Q1 		$506K Buy
+3,011
New +$437K 0.18% 130

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Waterfront Wealth's JAZZ Position: Q1 2026 in Review

Waterfront Wealth increased its Jazz Pharmaceuticals (JAZZ) stake by 12% in Q1 2026, buying an estimated $298K and bringing the position to 15,382 shares worth $2.91M. The position accounts for 0.53% of the portfolio, ranked #55.

Waterfront Wealth first reported a position in JAZZ in Q1 2022 and has held it in 17 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Waterfront Wealth held 15,382 shares of Jazz Pharmaceuticals worth $2.91M as of Q1 2026.
  • Waterfront Wealth bought 1,704 Jazz Pharmaceuticals shares in Q1 2026, an estimated $298K.
  • Jazz Pharmaceuticals made up 0.53% of Waterfront Wealth's portfolio in Q1 2026, its #55 holding.
  • Waterfront Wealth first reported a position in Jazz Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Waterfront Wealth's 13F filing for Q1 2026, filed 30 Apr 2026.